MANAGING CARDIOGENIC SHOCK IN TAKO-TSUBO SYNDROME: LEVOSIMENDAN AS A LIFE-SAVING SOLUTION

Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is an acute cardiac condition often precipitated by intense stress, leading to symptoms that mimic myocardial infarction. The management of cardiogenic shock in this context is challenging, as standard heart failure treatments, such as...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of advanced research (Indore) Vol. 12; no. 8; pp. 775 - 781
Main Authors Jaafari, M., Krimech, A., Dahmani, H., Ouaouicha, H., Hachem, G. EL, Salengro, E.
Format Journal Article
LanguageEnglish
Published 31.08.2024
Online AccessGet full text

Cover

More Information
Summary:Tako-Tsubo cardiomyopathy, also known as broken heart syndrome, is an acute cardiac condition often precipitated by intense stress, leading to symptoms that mimic myocardial infarction. The management of cardiogenic shock in this context is challenging, as standard heart failure treatments, such as Dobutamine, may worsen the condition. This case report presents an 82-year-old woman who developed cardiogenic shock due to Tako-Tsubo cardiomyopathy after a prolonged fall. She was successfully treated with Levosimendan, a drug that enhances myocardial contractility and reduces cardiac workload without increasing myocardial oxygen demand. This case underscores the importance of recognizing Tako-Tsubo cardiomyopathy in patients presenting with cardiogenic shock and highlights Levosimendan as a superior treatment option due to its beneficial effects on cardiac function and patient outcomes.
ISSN:2320-5407
2320-5407
DOI:10.21474/IJAR01/19314